Phase II clinical trial of pleurodesis with a 50% glucose solution for persistent air leak after pulmonary resection

Phase II clinical trial of pleurodesis with a 50% glucose solution for persistent air leak after pulmonary resection - Phase II clinical trial of pleurodesis with a 50% glucose solution for persistent air leak after pulmonary resection

Status

Recruiting

Phases

Phase 2

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000024987

Enrollment

Registered

2016-11-24

Start date

2016-10-14

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Postoperative persistent air leak or postoperative pneumothorax after pulmonary resection

Interventions

50% glucose solution group

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Postoperative persistent air leak or postoperative pneumothorax after pulmonary resection

Exclusion criteria

Exclusion criteria: 1) Patients with poor general condition caused by disease such as severe infection 2) Pregnant, breastfeeding , sexually active woman, or patients with no contraception. 3) Patients with severe diabetes mellitus 4) Patients registration to this study is deemed difficult due to mental disorders clinically relevant 5) Considered to be inappropriate for the participation in this study by the investigators 6) Patients unwilling to sign the consent form for participation

Design outcomes

Primary

Measure	Time frame
Rate of stopping air leakage after pleurodesis with a 50% glucose solution	—

Countries

Japan

Contacts

Public ContactYasushi Mizukami

Hokkaido Cancer Center Department of thoracic surgery

mizukami@sap-cc.go.jp011-811-9111

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026